Bandhan BSE Healthcare Index Fund
Bandhan BSE Healthcare Index Fund (Direct, Growth): Not rated by saplin yet. 1Y return 19.9%, expense ratio 0.33%. NAV ₹12.23 on 11 Nov 2026.
Loading the full analysis…
Bandhan BSE Healthcare Index Fund (Direct, Growth): Not rated by saplin yet. 1Y return 19.9%, expense ratio 0.33%. NAV ₹12.23 on 11 Nov 2026.
Loading the full analysis…
The Direct plan's total expense ratio is 0.33% a year, against a median of 0.54% for index funds. The Regular plan costs more because it pays a distributor's commission.
Abhishek Jain (since 8 Mar 2025); Mayuresh Nagvekar (since 17 Feb 2026).
Sun Pharmaceutical Industries 11.99%, Divi's Laboratories 7.73%, Laurus Labs 5.81%, Apollo Hospitals Enterprise 5.36%, Dr. Reddy's Laboratories 5.14% of the portfolio, as of 31 Oct 2026.
1 year: 19.9% (category median 1.2%). Past returns do not predict future ones.
About ₹22 cr (AMFI's average for the latest quarter).